Biomarker shows promise for potential treatment of facioscapulohumeral muscular dystrophy
There is currently no effective treatment for facioscapulohumeral muscular dystrophy (FSHD), one of the most common neuromuscular diseases, which is caused by an abnormal expression of the transcription factor DUX4. Investigators ...
Feb 15, 2022
0
6